Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Rosell, Rafael; Dafni, Urania; Felip, Enriqueta; Curioni-Fontecedro, Alessandra; Gautschi, Oliver; Peters, Solange; Massutí, Bartomeu; Palmero, Ramon; Aix, Santiago Ponce; Carcereny, Enric; Früh, Martin; Pless, Miklos; Popat, Sanjay; Kotsakis, Athanasios; Cuffe, Sinead; Bidoli, Paolo; Favaretto, Adolfo; Froesch, Patrizia; Reguart, Noemí; Puente, Javier; Coate, Linda; Barlesi, Fabrice; Rauch, Daniel; Thomas, Michael; Camps, Carlos; Gómez-Codina, Jose; Majem, Margarita; Porta, Rut; Shah, Riyaz; Hanrahan, Emer; et al (2017). Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. Lancet Respiratory Medicine, 5(5):435-444.

Gautschi, Oliver; Rothschild, Sacha I; Li, Qiyu; Matter-Walstra, Klazien; Zippelius, Alfred; Betticher, Daniel C; Früh, Martin; Stahel, Rolf A; Cathomas, Richard; Rauch, Daniel; Pless, Miklos; Peters, Solange; Froesch, Patrizia; Zander, Thilo; Schneider, Martina; Biaggi, Christine; Mach, Nicolas; Ochsenbein, Adrian F; Swiss Group for Clinical Cancer Research (2017). Bevacizumab plus pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous non-small-cell lung cancer: Update from the swiss group for clinical cancer research (SAKK) 19/09 trial. Clinical Lung Cancer, 18(3):303-309.

Gramatzki, Dorothee; Dehler, Silvia; Rushing, Elisabeth Jane; Zaugg, Kathrin; Hofer, Silvia; Yonekawa, Yasuhiro; Bertalanffy, Helmut; Valavanis, Anton; Korol, Dimitri; Rohrmann, Sabine; Pless, Miklos; Oberle, Joachim; Roth, Patrick; Ohgaki, Hiroko; Weller, Michael (2016). Glioblastoma in the canton of Zurich, Switzerland revisited: 2005 to 2009. Cancer, 122(14):2206-2215.

Gautschi, Oliver; Mach, Nicholas; Rothschild, Sacha I; Li, Qiyu; Stahel, Rolf A; Zippelius, Alfred; Cathomas, Richard; Früh, Martin; Betticher, Daniel C; Peters, Solange; Rauch, Daniel; Feilchenfeldt, Jonas; Bubendorf, Lukas; Savic, Spasenija; Jaggi, Rolf; Leibundgut, Elisabeth Oppliger; Largiadèr, Carlo; Brutsche, Martin; Pilop, Christiane; Stalder, Lukas; Pless, Miklos; Ochsenbein, Adrian F (2015). Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09. Clinical Lung Cancer, 16(5):358-365.

Pless, Miklos; Stupp, Roger; Ris, Hans-Beat; Stahel, Rolf A; Weder, Walter; Thierstein, Sandra; Gerard, Marie-Aline; Xyrafas, Alexandros; Früh, Martin; Cathomas, Richard; Zippelius, Alfred; Roth, Arnaud; Bijelovic, Milorad; Ochsenbein, Adrian; Meier, Urs R; Mamot, Christoph; Rauch, Daniel; Gautschi, Oliver; Betticher, Daniel C; Mirimanoff, René-Olivier; Peters, Solange (2015). Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet, 386(9998):1049-1056.

Strebel, Räto T; Sulser, Tullio; Schmid, Hans-Peter; Gillessen, Silke; Fehr, Martin; Huber, Urs; Pless, Miklos; Morant, Rudolf; Winterhalder, Ralph; Cathomas, Richard (2013). Multidisciplinary care in patients with prostate cancer: room for improvement. Supportive Care in Cancer, 21(8):2327-2333.

Gautschi, Oliver; Dingemans, Anne-Marie; Crowe, Susanne; Peters, Solange; Roder, Heinrich; Grigorieva, Julia; Roder, Joanna; Zappa, Francesco; Pless, Miklos; Brutsche, Martin; Baty, Florent; Bubendorf, Lukas; Hsu Schmitz, Shu-Fang; Na, Kyung-Jae; Carbone, David; Stahel, Rolf; Smit, Egbert (2013). VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. Lung Cancer, 79(1):59-64.

This list was generated on Tue Jan 23 13:22:49 2018 CET.